- Latest available (Revised)
- Original (As adopted by EU)
Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
1.The summary of the product characteristics referred to in point (a) of Article 33(1) shall contain, in the order indicated below, the following information:
(a)name of the veterinary medicinal product followed by its strength and pharmaceutical form and, where applicable, a list of the names of the veterinary medicinal product, as authorised in different Member States;
(b)qualitative and quantitative composition of the active substance or substances and qualitative composition of excipients and other constituents stating their common name or their chemical description and their quantitative composition, if that information is essential for proper administration of the veterinary medicinal product;
(c)clinical information:
target species;
indications for use for each target species;
contra-indications;
special warnings;
special precautions for use, including in particular special precautions for safe use in the target species, special precautions to be taken by the person administering the veterinary medicinal product to the animals and special precautions for the protection of the environment;
frequency and seriousness of adverse events;
use during pregnancy, lactation or lay;
interaction with other medicinal products and other forms of interaction;
administration route and dosage;
symptoms of overdose and, where applicable, emergency procedures and antidotes in the event of overdose;
special restrictions for use;
special conditions for use, including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products in order to limit the risk of development of resistance;
if applicable, withdrawal periods, even if such periods are zero;
(d)pharmacological information:
Anatomical Therapeutic Chemical Veterinary Code (‘ATCvet Code’);
pharmacodynamics;
pharmacokinetics.
In case of an immunological veterinary medicinal product, instead of points (i), (ii) and (iii), immunological information;
(e)pharmaceutical particulars:
major incompatibilities;
shelf life, where applicable after reconstitution of the medicinal product or after the immediate packaging has been opened for the first time;
special precautions for storage;
nature and composition of immediate packaging;
requirement to use take-back schemes for veterinary medicinal products for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products and, if appropriate, additional precautions regarding hazardous waste disposal of unused veterinary medicinal products or waste materials derived from the use of such products;
(f)name of the marketing authorisation holder;
(g)marketing authorisation number or numbers;
(h)date of the first marketing authorisation;
(i)date of the last revision of the summary of the product characteristics;
(j)if applicable, for veterinary medicinal products referred to in Article 23 or 25, the statement:
‘marketing authorisation granted for a limited market and therefore assessment based on customised requirements for documentation’; or
‘marketing authorisation in exceptional circumstances and therefore assessment based on customised requirements for documentation’;
(k)information on the collection systems referred to in Article 117 applicable to the veterinary medicinal product concerned;
(l)classification of the veterinary medicinal product as referred to in Article 34 for each Member State in which it is authorised.
2.In the case of generic veterinary medicinal products, the parts of the summary of the product characteristics of the reference veterinary medicinal product that refer to indications or pharmaceutical forms which are protected by patent law in a Member State at the time of placing of the generic veterinary medicinal product on the market may be omitted.
The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: